Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $0.34 in the prior trading day, Helius Medical Technologies Inc (NASDAQ: HSDT) closed at $0.21, down -37.92%. In other words, the price has decreased by -$37.92 from its previous closing price. On the day, 13.63 million shares were traded. HSDT stock price reached its highest trading level at $0.2499 during the session, while it also had its lowest trading level at $0.2034.
Ratios:
Our goal is to gain a better understanding of HSDT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.13 and its Current Ratio is at 1.69. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Noble Capital Markets on March 24, 2021, initiated with a Outperform rating and assigned the stock a target price of $20.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HSDT now has a Market Capitalization of 665728 and an Enterprise Value of -997578. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.26 while its Price-to-Book (P/B) ratio in mrq is 0.07. Its current Enterprise Value per Revenue stands at -2.299 whereas that against EBITDA is 0.069.
Stock Price History:
The Beta on a monthly basis for HSDT is 0.96, which has changed by -0.9856169 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, HSDT has reached a high of $24.00, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is -92.97%, while the 200-Day Moving Average is calculated to be -97.04%.
Shares Statistics:
The stock has traded on average 5.97M shares per day over the past 3-months and 14561370 shares per day over the last 10 days, according to various share statistics. A total of 0.53M shares are outstanding, with a floating share count of 0.50M. Insiders hold about 5.46% of the company’s shares, while institutions hold 77.83% stake in the company. Shares short for HSDT as of 1749772800 were 2335408 with a Short Ratio of 0.39, compared to 1747267200 on 7777. Therefore, it implies a Short% of Shares Outstanding of 2335408 and a Short% of Float of 74.02.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
1 analysts predict $75k in revenue for the current quarter. It ranges from a high estimate of $75k to a low estimate of $75k. As of the current estimate, Helius Medical Technologies Inc’s year-ago sales were $182kFor the next quarter, 1 analysts are estimating revenue of $110k. There is a high estimate of $110k for the next quarter, whereas the lowest estimate is $110k.
A total of 1 analysts have provided revenue estimates for HSDT’s current fiscal year. The highest revenue estimate was $374k, while the lowest revenue estimate was $374k, resulting in an average revenue estimate of $374k. In the same quarter a year ago, actual revenue was $520kBased on 1 analysts’ estimates, the company’s revenue will be $655k in the next fiscal year. The high estimate is $655k and the low estimate is $655k.
